Across TCGA pan-cancer cohorts, CTAG1B RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated CTAG1B data layer.
The strongest signal is observed in kidney chromophobe (KICH), where higher CTAG1B RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CTAG1B expression acts as an unfavorable survival marker, although some lineages such as SARC show a favorable association.
KICH, BLCA, and MESO are the cancer types where CTAG1B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.